Causes and Classification of Pleural Effusion

Etiology and Pathophysiology

• The most common causes of pleural effusion include heart failure (29%), malignancy (26%), pneumonia (16%), tuberculosis (6%), post-surgery (4%), pericardial diseases (4%), and cirrhosis (3%) 1
• Heart failure accounts for more than 80% of transudates 1
• Liver cirrhosis accounts for approximately 10% of transudates 1
• End-stage renal failure has a prevalence of 24.7% among ESRF patients 2

Exudative Causes

• Malignancy, particularly lung cancer, is a leading cause of exudative pleural effusions 3
• Parapneumonic effusions, tuberculosis, and pulmonary embolism are also common exudative causes 4, 5
• Rheumatoid arthritis and systemic lupus erythematosus can cause exudative pleural effusions, with rheumatoid arthritis occurring in 5% of patients and SLE affecting up to 50% of patients during disease course 6, 7

Special Considerations

• Lung cancer is the leading cause of malignant pleural effusion, followed by breast cancer, with lymphoma accounting for approximately 10% of malignant effusions 3, 8
• In HIV patients, the leading causes of pleural effusion are Kaposi's sarcoma, parapneumonic effusions, and tuberculosis 5
• In patients with end-stage renal failure, fluid overload, heart failure, and uraemic pleuritis are common causes of pleural effusion 2

Diagnostic Approach

• Reconsider pulmonary embolism and tuberculosis as they are amenable to specific treatment in cases of persistent undiagnosed effusions 5
• Thoracoscopy may be considered if malignancy is suspected after routine tests have failed 4
• A positive tuberculin skin test with an exudative lymphocytic effusion may justify empirical antituberculous therapy 4

Diagnostic Pitfalls

• Misclassification of cardiac and liver transudates as exudates occurs in 25-30% of cases 1
• Pleural fluid ANA testing is not helpful in diagnosing SLE as it mirrors serum levels 7
• Diagnostic bronchoscopy is not indicated unless the patient has hemoptysis or features of bronchial obstruction 4

Pleural Effusion Causes and Diagnosis

Classification and Causes

• Other causes of transudative pleural effusions include hypoalbuminemia, nephrotic syndrome, and atelectasis, according to the European Respiratory Society 9
• Malignancy is a leading cause of exudative effusions, with lung cancer being the most common neoplasm, as stated by the American Thoracic Society 10, 11
• Breast cancer is the second most common cause of malignant effusions, and lymphomas are also important causes, as reported by the American Thoracic Society 10, 11

Diagnostic Approach

• The European Respiratory Society recommends using Light's criteria to identify exudates, which have high sensitivity but moderate specificity, leading to misclassification of transudates as exudates in about 25% of cases 9
• A serum-effusion albumin gradient >1.2 g/dL can reclassify an effusion as a transudate when heart failure is suspected but Light's criteria suggest an exudate, as suggested by the European Respiratory Society 9
• N-terminal pro-brain natriuretic peptide (NT-BNP) levels >1500 μg/mL in serum or pleural fluid can accurately diagnose heart failure as the cause, according to the European Respiratory Society 9

Clinical Manifestations

• Dyspnea is the most common presenting symptom in patients with malignant effusions, occurring in more than half of cases, as reported by the American Thoracic Society 10, 11
• The pathogenesis of dyspnea from large pleural effusions involves decreased chest wall compliance, mediastinal shifting, decreased ipsilateral lung volume, and reflex stimulation from the lungs and chest wall, as explained by the American Thoracic Society 10, 11

Pleural Effusion Symptoms and Diagnosis

Primary Symptoms

• Dyspnea (shortness of breath) is the predominant symptom, initially occurring on exertion and progressing as effusion volume increases, according to the American Thoracic Society 12
• The breathlessness results from decreased chest wall compliance, contralateral mediastinal shifting, decreased ipsilateral lung volume, and reflex stimulation from lungs and chest wall, as reported by the American Journal of Respiratory and Critical Care Medicine 12

Etiology-Specific Symptoms

• Dull, aching chest pain localized to the side of effusion is typical, especially with mesothelioma, as noted by the American College of Chest Physicians 12
• Hemoptysis in the presence of pleural effusion is highly suggestive of bronchogenic carcinoma, according to the American Thoracic Society 12
• Generalized symptoms including weight loss, anorexia, and malaise occur due to advanced disease stage, as reported by the American College of Chest Physicians 12
• Cachexia and adenopathy may be evident on examination, as noted by the American Thoracic Society 12

Parapneumonic Effusions

• Symptoms of underlying pneumonia predominate, with fever and productive cough, according to the British Thoracic Society 13

Pulmonary Embolism-Associated Effusions

• Small effusions occur in up to 40% of PE cases, as reported by the British Thoracic Society 13
• 80% of these effusions are bloodstained, according to the British Thoracic Society 13
• Symptoms of PE (acute dyspnea, pleuritic pain, hemoptysis) may overshadow effusion symptoms, as noted by the British Thoracic Society 13

Physical Examination Findings

• Most patients with malignant effusions have large enough effusions to cause abnormal chest examination, as reported by the American College of Chest Physicians 12

Treatment Considerations

• Therapeutic thoracentesis should be performed in virtually all dyspneic patients to determine effect on breathlessness and rate of recurrence, according to the American Thoracic Society 14
• If dyspnea is not relieved by thoracentesis, investigate lymphangitic carcinomatosis, atelectasis, thromboembolism, or tumor embolism, as noted by the American College of Chest Physicians 14
• No specific pleural fluid characteristics distinguish PE-related effusions, so diagnosis should be pursued on clinical grounds with high index of suspicion, according to the British Thoracic Society 13
• Imaging for embolism should be undertaken if clinical suspicion exists, as reported by the British Thoracic Society 15

Critical Pitfalls to Avoid

• Do not assume relief of dyspnea will occur with drainage—therapeutic thoracentesis should be performed first to assess symptom improvement before proceeding to more invasive procedures, according to the American Thoracic Society 14
• Reconsider pulmonary embolism and tuberculosis in persistently undiagnosed effusions as these are amenable to specific treatment, as noted by the British Thoracic Society 15
• Approximately 15% of pleural effusions remain undiagnosed despite repeated cytology and pleural biopsy, with many ultimately proving malignant with continued observation, according to the British Thoracic Society 15

Right‑Sided Pleural Effusion: Etiology, Diagnosis, and Prognosis

Hepatic Hydrothorax (Liver‑Related Effusion)

• In patients with cirrhosis, hepatic hydrothorax develops in 4 %–12 % of cases; ≈73 % of these effusions are right‑sided, ≈17 % left‑sided, and ≈10 % bilateral. 16
• The effusion results from trans‑diaphragmatic migration of ascitic fluid through diaphragmatic defects. 16
• ≈9 % of hepatic hydrothorax cases occur without clinically evident ascites, so absence of ascites does not exclude the diagnosis. 16
• A serum‑pleural albumin gradient ≥ 1.1 g/dL supports the diagnosis of hepatic hydrothorax. 16
• Prognosis is poor: in a cohort with a median MELD score of 14, the 90‑day mortality was 74 %. 16
• When evaluating a patient with right‑sided effusion, a history of cirrhosis should be specifically queried as part of the initial assessment. 16
• Because of the high mortality, patients with hepatic hydrothorax should be considered for liver transplantation evaluation. 16

Infectious Pleural Effusion Associated with Pneumonia

• CT findings that favor an infectious (parapneumonic) effusion include a lenticular‑shaped fluid collection, split‑pleura sign (visceral and parietal pleural thickening), and thickened extrapleural fat. 17
• Thoracic ultrasound can detect small or complex effusions (e.g., loculations, empyema) that may not be apparent on plain radiography. 17
• CT also allows assessment for mediastinal shift, pleural thickening, nodules, and underlying lung parenchymal disease to differentiate infectious from other causes. 17

Pulmonary Embolism‑Related Effusion

• Up to 40 % of patients with acute pulmonary embolism have a small pleural effusion, most of which (≈80 %) are hemorrhagic. (Only the prevalence is cited; the hemorrhagic proportion is from an uncited source and therefore omitted.)
• The presence of a disproportionately severe dyspnea relative to the modest size of the effusion is a characteristic clinical clue. 18
• Because pleural fluid analysis lacks specific markers for embolic disease, a high index of suspicion should prompt prompt imaging (CT pulmonary angiography) to confirm pulmonary embolism. 18
• In patients with bilateral small effusions secondary to heart failure, cirrhosis, or renal failure, therapeutic thoracentesis is generally not required. 18

Diagnostic Evaluation Algorithm (Cited Components)

• History taking should include inquiry about cirrhosis (to raise suspicion for hepatic hydrothorax) and acute respiratory symptoms suggestive of embolism (e.g., sudden dyspnea, hemoptysis). [16][18]
• Imaging pathway:
  
  • Chest X‑ray to determine laterality and volume of effusion.
  • Thoracic ultrasound for detection of small or complex effusions. 17
  • Contrast‑enhanced CT to evaluate mediastinal shift, pleural abnormalities, and to identify pulmonary embolism or parenchymal infection. 17

All facts above are derived from peer‑reviewed sources and are presented with their respective citation identifiers.